Literature DB >> 43553

Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepate.

D J Greenblatt, R I Shader, J S Harmatz, A Georgotas.   

Abstract

Plasma concentrations of desmethyldiazepam (DMDZ) and intensity of self-rated sedation (SRS) were measured at multiple points in time during 6 h after a single 15 mg oral dose of clorazepate dipotassium. Mean plasma DMDZ levels and mean SRS scores both became maximal at 1.0--2.5 h after drug dosage. By 6 h, however, mean SRS had returned to the predrug baseline score while mean DMDZ concentration fell only slighty from the maximum value. Disappearance of SRS despite persistence of high DMDZ levels might be due to adaptation or tolerance. If this is the case, subjective effects of benzodiazepines may depend upon duration of drug exposure as well as dose and concentration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43553     DOI: 10.1007/bf00428321

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Determination of desmethyldiazepam in plasma by electron-capture GLC: application to pharmacokinetic studies of clorazepate.

Authors:  D J Greenblatt
Journal:  J Pharm Sci       Date:  1978-03       Impact factor: 3.534

2.  Diazepam actions and plasma concentrations following ethanol ingestion.

Authors:  S M MacLeod; H G Giles; G Patzalek; J J Thiessen; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

3.  Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide.

Authors:  R I Shader; A Georgotas; D J Greenblatt; J S Harmatz; M D Allen
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

4.  Conflict behavior in the squirrel monkey: effects of chlordiazepoxide, diazepam and N-desmethyldiazepam.

Authors:  J Sepinwall; F S Grodsky; L Cook
Journal:  J Pharmacol Exp Ther       Date:  1978-01       Impact factor: 4.030

5.  Modification of depressant and disinhibitory action of flurazepam during short term treatment in the rat.

Authors:  G Cannizzaro; S Nigito; P M Provenzano; T Vitikova
Journal:  Psychopharmacologia       Date:  1972

6.  Development of tolerance to tranquillizers in the rat.

Authors:  K Matsuki; T Iwamoto
Journal:  Jpn J Pharmacol       Date:  1966-06

7.  Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam.

Authors:  D L Margules; L Stein
Journal:  Psychopharmacologia       Date:  1968

8.  Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment.

Authors:  C Maxwell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

9.  Rapid recovery from massive diazepam overdose.

Authors:  D J Greenblatt; E Woo; M D Allen; P J Orsulak; R I Shader
Journal:  JAMA       Date:  1978-10-20       Impact factor: 56.272

10.  Absorption rate, blood concentrations, and early response to oral chlordiazepoxide.

Authors:  D J Greenblatt; R I Shader; J S Harmatz; K Franke; J Koch-Weser
Journal:  Am J Psychiatry       Date:  1977-05       Impact factor: 18.112

View more
  4 in total

1.  Central effects during the continuous osmotic infusion of a benzodiazepine (triazolam).

Authors:  D D Breimer; R Jochemsen; H A Kamphuisen; A N Nicholson; M B Spencer; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

2.  Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity.

Authors:  D N Stephens; H H Schneider
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Clorazepate use may prevent alcohol withdrawal convulsions.

Authors:  V G Haddox; T G Bidder; L E Waldron; P Derby; S M Achen
Journal:  West J Med       Date:  1987-06

4.  Kinetic and dynamic interaction of brotizolam and ethanol.

Authors:  J M Scavone; D J Greenblatt; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.